Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Cardium Therapeutics, Inc. (CXM) To Present Excellagen Posters At Desert Foot 9th Annual High Risk Diabetic Foot Conference

|Includes: Cardium Therapeutics, Inc (CXM)

Cardium Therapeutics, an asset-based health sciences and regenerative medicine company, announced this morning that the company will be displaying two Excellagen® poster presentations at the Desert Foot 2012 High Risk Diabetic Foot Conference being held this week in Phoenix, AZ.

Arthur J. Tallis, DPM, President and Medical Director of Associated Foot & Ankle Specialists in Phoenix, AZ, has been chosen to present the results of three Excellagen case studies, including a venous leg ulcer, neuropathic diabetic foot ulcer, and dehisced surgical wound. In addition, Howard M. Kimmel, DPM, MBA, FACFAS, Senior Clinical Instructor, Case Western Reserve University School of Medicine in Cleveland, OH, will display two case studies involving non-healing diabetic foot ulcers. The majority of the patients' wounds were classified as chronic and non-healing despite prior treatments, including Dermagraft.

Drs. Tallis and Kimmel's poster presentations can be viewed at and additional Excellagen case studies are available at

Cardium also reported the publication of the Profiles in Excellence 2012 article, "Excellagen - Advanced Wound Care Made Simple," in the October issue of Podiatry Management. The article highlights Excellagen's ease of use, illustrating how easily it fits into existing wound care practices to save physicians time. The product is superior to other treatments that require daily dressing changes and frequent product applications and physician visits. The article can be viewed at

For more information on Excellagen, visit

For more information on Cardium Therapeutics, visit

For additional information, visit

Please see disclaimer on the MissionIR website